Work

Erratum to: Retrospective analysis of pacritinib in patients with myelofibrosis and severe thrombocytopenia

Year: 2024

Type: erratum

Abstract: The number for the Pacritinib group was erroneously published as 17.9 (5/28) and should be 25.0 (19/76).The corrected Table 2 is shown here.

Source: Haematologica

DOI: 10.3324/haematol.2023.284815

Authors: Srdan Verstovsek, Ruben Mesa, Moshe Talpaz, Jean-Jacques Kiladjian, Claire N. Harrison, Stephen T. Oh, Alessandro M. Vannucchi, Raajit Rampal, Bart L. Scott, Sarah A. Buckley, Adam R. Craig, Karisse Roman-Torres, John O. Mascarenhas

Institutions: The University of Texas MD Anderson Cancer Center, Mayo Clinic, Mayo Clinic in Arizona, University of Michigan, U-M Rogel Cancer Center, Hôpital Saint-Louis, Université Paris Diderot, Guy's and St Thomas' NHS Foundation Trust, Washington University in St. Louis, Azienda Ospedaliero-Universitaria Careggi, University of Florence, Memorial Sloan Kettering Cancer Center, Fred Hutch Cancer Center, CTI BioPharma (United States), Icahn School of Medicine at Mount Sinai

Language: English

Topic: Myeloproliferative Neoplasms: Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,157

OpenAlex ID: W4393389942

Cites: 1

Cited by:

Related to: 10